A phase I/II trial of belinostat in combination with cisplatin, doxorubicin, and cyclophosphamide in thymic epithelial tumors: a clinical and translational study.
about
Epigenetic treatment of solid tumours: a review of clinical trialsThe 2015 World Health Organization Classification of Tumors of the Thymus: Continuity and ChangesUGT genotyping in belinostat dosingThymic Epithelial Tumors phenotype relies on miR-145-5p epigenetic regulationHistone deacetylase inhibitors in clinical studies as templates for new anticancer agents.The effects of short-term fasting on tolerance to (neo) adjuvant chemotherapy in HER2-negative breast cancer patients: a randomized pilot study.Alterations of immune cell subsets in relapsed, thymoma-associated minimal change disease: A case report.Predicting chemotherapeutic drug combinations through gene network profilingThe interplay of epigenetic therapy and immunity in locally recurrent or metastatic estrogen receptor-positive breast cancer: Correlative analysis of ENCORE 301, a randomized, placebo-controlled phase II trial of exemestane with or without entinostaVorinostat and hydroxychloroquine improve immunity and inhibit autophagy in metastatic colorectal cancer.Blocking downstream signaling pathways in the context of HDAC inhibition promotes apoptosis preferentially in cells harboring mutant Ras.Immunogenic cancer cell death selectively induced by near infrared photoimmunotherapy initiates host tumor immunity.Belinostat for the treatment of relapsed or refractory peripheral T-cell lymphoma.PI3K as a Potential Therapeutic Target in Thymic Epithelial Tumors.Pharmacogenomics and histone deacetylase inhibitors.A phase I clinical trial of the effect of belinostat on the pharmacokinetics and pharmacodynamics of warfarin.Novel Agents in the Treatment of Thymic Malignancies.Incidence, Diagnosis, and Management of QT Prolongation Induced by Cancer Therapies: A Systematic Review.UGT1A1 genotype-dependent dose adjustment of belinostat in patients with advanced cancers using population pharmacokinetic modeling and simulation.Assessment of new HDAC inhibitors for immunotherapy of malignant pleural mesothelioma.
P2860
Q26773803-5B1A41D2-1C37-4BA3-B612-C0B93B8580B2Q28087370-2AF839D1-576A-4B0D-991B-5FFCB7D790DAQ33429235-07EF8E84-083E-4F10-A21F-D0F28DE7CB2CQ33655180-0CE323BE-48B5-4B22-BFB6-E9B7845E018AQ35214924-165C30B6-17C9-409E-8021-CE4B74C95027Q35799993-363B20DB-2438-4CA7-9BFD-B9EFE704689AQ35870236-FE57B043-D6E5-40E2-BDF4-4AE32B1B3D6CQ36500982-79ABD9AA-A798-4E73-BB70-6919F75B7EFBQ37477372-926DBFD3-454A-46E3-8CF0-A8E409700C1EQ37644824-94B49166-BF43-45DD-8620-73E48EB0DA98Q37684405-131B5427-BF29-443F-91D6-38D307127451Q37705851-697B3F83-D285-4269-9808-0C58402A5645Q38752460-99651E8D-8136-4438-AF3C-3A5392B8B62AQ38775158-773514D6-11DF-44EF-8C94-D6C65A4A5397Q38987332-1891142A-CEF6-4A70-AB40-7D78709DBC85Q47637390-E53BA210-9314-4AAE-8A55-81E97517923AQ48696917-780E787B-EB7A-460C-BC07-CEEF9A209AADQ49244147-7E53C63A-9F70-498A-9D43-2DE8948DA790Q50546142-3DE85E70-193D-4B89-8B74-D9D55C556CAFQ55447998-EE004E7E-6F80-4FFA-9139-F3383FA00B1D
P2860
A phase I/II trial of belinostat in combination with cisplatin, doxorubicin, and cyclophosphamide in thymic epithelial tumors: a clinical and translational study.
description
2014 nî lūn-bûn
@nan
2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
A phase I/II trial of belinost ...... nical and translational study.
@ast
A phase I/II trial of belinost ...... nical and translational study.
@en
type
label
A phase I/II trial of belinost ...... nical and translational study.
@ast
A phase I/II trial of belinost ...... nical and translational study.
@en
prefLabel
A phase I/II trial of belinost ...... nical and translational study.
@ast
A phase I/II trial of belinost ...... nical and translational study.
@en
P2093
P2860
P50
P921
P1476
A phase I/II trial of belinost ...... inical and translational study
@en
P2093
Ari Frosch
Ariel Lopez-Chavez
Arun Rajan
Barbara Scepura
Christophe E Redon
Cody J Peer
Corey A Carter
David S Schrump
Jane B Trepel
Min-Jung Lee
P2860
P304
P356
10.1158/1078-0432.CCR-14-0968
P407
P577
2014-09-04T00:00:00Z